Close Menu

NEW YORK (GenomeWeb) – CareDx announced today that Allenex shareholders representing about 98 percent of the company's shares have accepted CareDx's takeover offer, and that it expects to close the deal on or around April 13.

CareDx acquired a 78 percent majority stake in the Swedish transplant diagnostics firm in December 2015. At the time, the firm also said that it planned to buy the remaining shares in the first quarter of 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.